Navigation Links
EpiCept to Present Preclinical Studies of EPC2407 in Combination With Anti-Angiogenic and Chemotherpeutic Agents at the AACR-NCI-EORTC International Conference
Date:10/22/2007

ccessful, the risk that our ASAP technology will not yield any successful product candidates, the risk that clinical trials for NP-1 or EPC 2407 will not be successful, that NP-1 or EPC 2407 will not receive regulatory approval or achieve significant commercial success, the risk that our other product candidates that appeared promising in early research and clinical trials do not demonstrate safety and/or efficacy in larger-scale or later stage clinical trials, the risk that EpiCept will not obtain approval to market any of its product candidates, the risks associated with dependence upon key personnel, the risks associated with reliance on collaborative partners and others for further clinical trials, development, manufacturing and commercialization of our product candidates; the cost, delays and uncertainties associated with our scientific research, product development, clinical trials and regulatory approval process; our history of operating losses since our inception; competition; litigation; risks associated with prior material weaknesses in our internal controls; and risks associated with our ability to protect our intellectual property. These factors and other material risks are more fully discussed in EpiCept's periodic reports, including its reports on Forms 8-K, 10-Q and 10-K and other filings with the U.S. Securities and Exchange Commission. You are urged to carefully review and consider the disclosures found in EpiCept's filings which are available at http://www.sec.gov or at http://www.epicept.com. You are cautioned not to place undue reliance on any forward-looking statements, any of which could turn out to be wrong due to inaccurate assumptions, unknown risks or uncertainties or other risk factors.

* Azixa is a registered trademark of Myriad Genetics, Inc.

EPCT-GEN


'/>"/>
SOURCE EpiCept Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. EpiCept Accelerates Development of Phase I Clinical Study for Cancer
2. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
3. Researchers Present Ways To Reduce The Risk Of Dementia
4. Researchers Present Data Regarding The Efficiency Of Herbs
5. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
6. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
7. Drug Reactions First Present Themselves In The Mouth
8. Reminiscing Into The Past Makes You Dissatisfied With The Present
9. Living In The Past Indicates Dissatisfaction With Present
10. Movies Represent Coma In A Wrong Way
11. Onchocerciasis: Presentation And Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Comparemedicalinsurance.info has released a new blog ... who have health problems. , A pre-existing medical ... clients. No medical exam life insurance plans offer a ... a lot easier. , No medical exam life ... temporary protection, while others will insure the client for ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 Discount-Dress.com, an ... and women’s special occasion outfits, is doing its best ... its dresses at discounted rates, up to 75% off. ... new blog . Also, it has unveiled many ... cocktail party dresses, gorgeous lace wedding dresses, purple prom ...
(Date:7/24/2014)... July 24, 2014 Follow ... a rapidly expanding sector in the in-vitro diagnostics ... collection devices, new detection technologies, computers, and automation ... versatility, and speed. In addition to disease diagnosis, ... benefits in patient stratification, drug regimen selection, therapeutic ...
(Date:7/24/2014)... Hanover, MA (PRWEB) July 24, 2014 ... Foundation will be on hand to provide educational and ... 11th Annual Meeting next week in Colorado Springs. , ... from some of the most renowned neurointerventional research ... problem solving and innovating together (with or at) symposiums, ...
(Date:7/24/2014)... July 24, 2014 “To care for him ... and his orphan.” The inspired quote is attributed to Abraham ... of Veterans Affairs (VA). And yet the reality of Lincoln’s ... in exchange for their service in times of conflict, leaves ... represents many veterans locked in a battle they never expected ...
Breaking Medicine News(10 mins):Health News:Life Insurance Without Examinations for Clients Who Have Pre-Existing Medical Conditions 2Health News:Discount-Dress.com Announces the Launch of Its New Blog and Publishes Articles About Its Fabulous Special Occasion Dresses 2Health News:Increasing Molecular Level Understanding of Disease State & Metabolism Drives the Molecular Diagnostics Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Increasing Molecular Level Understanding of Disease State & Metabolism Drives the Molecular Diagnostics Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Increasing Molecular Level Understanding of Disease State & Metabolism Drives the Molecular Diagnostics Market, According to New Report by Global Industry Analysts, Inc. 4Health News:Brain Aneurysm Foundation Provides Key Support to NeuroIntervential Physicians 2Health News:LawyersandSettlements.com Interviews Veterans Benefits Attorney Shanin Specter about Recent VA Hospital Reports 2Health News:LawyersandSettlements.com Interviews Veterans Benefits Attorney Shanin Specter about Recent VA Hospital Reports 3Health News:LawyersandSettlements.com Interviews Veterans Benefits Attorney Shanin Specter about Recent VA Hospital Reports 4Health News:LawyersandSettlements.com Interviews Veterans Benefits Attorney Shanin Specter about Recent VA Hospital Reports 5
... 19 DaVita Inc., a,leading provider of kidney ... (CKD) and kidney failure, today announced that they ... patients,against influenza (flu). Today,s announcement highlights DaVita,s proven ... services, setting the standard for,superior clinical care. , ...
... Lecture for Healthcare ProfessionalsVOORHEES, N.J., Jan. 19 ... being seen in older adults, especially among residents ... complicated by the emergence of a virulent strain ... rates of morbidity and mortality. Implementing strategies for ...
... Center invites women of all ages to attend Girls, ... 6:00 p.m. at Northgate Mall. The event, sponsored by ... more. The Northwest Hospital booth will feature free ... well as body mass index (BMI) and waist measurement ...
... Educational CD provides veterinarians with a new way to understanding and ... ... January 19, 2009 -- Merial today announced the availability of an ... the complex subject of heartworm prevention and treatment in dogs. Launched ...
... Inc., a world leader in handheld x-ray technologies, announced ... patent for its NOMAD Handheld X-ray System. The latest ... having all components of the x-ray system in the ... the world,s first handheld x-ray system. Aribex was previously ...
... Fla., Jan. 19 As the unemployment rate grows, ... who are coping with the,loss of health insurance. COBRA ... but while many workers have the right to,purchase such ... cost is,often prohibitively high. A November 2008 study by ...
Cached Medicine News:Health News:DaVita 'Flu Fighter Program' Vaccinates 85 Percent of Patients 2Health News:Clostridium difficile Infection in Long-Term Care: Tailored Approaches to Management 2Health News:Northwest Hospital Sponsors Girls' Day Out Event at Northgate Mall 2Health News:Heartworm CD by Merial Offers Unique Approach to Managing this Deadly Condition 2Health News:Heartworm CD by Merial Offers Unique Approach to Managing this Deadly Condition 3Health News:Aribex(R) Awarded Patents for Handheld X-ray 2Health News:Is Your Business Ready for the COBRA Premium Subsidy? 2
(Date:7/24/2014)... Calif. , July 24, 2014  Xencor, Inc. ... developing engineered monoclonal antibodies for the treatment of autoimmune ... it will release second quarter financial results after market ... host a webcast and conference call the same day ... the financial results and provide a corporate update. ...
(Date:7/24/2014)... 2014 MedVantx, Inc., the company that ... channel in physician offices, MedStart Connect, today announced ... to medication non-adherence and hospital readmission rates specified ... of the Annals of Internal ... frequent changes in generic medication pill color and ...
(Date:7/24/2014)... July 24, 2014 , Second-quarter ... of U.S. patent expirations for Cymbalta and Evista, partially ... , Expense management initiatives resulted in 11 ... , Second-quarter 2014 earnings per share were $0.68 ... , New oncology research collaboration with Immunocore in ...
Breaking Medicine Technology:Xencor to Host Second Quarter 2014 Financial Results Webcast and Conference Call 2Medication Non-Adherence Issue Highlighted in Annals of Internal Medicine Study Could Be Eliminated by a New Direct-to-Consumer Delivery Channel Ensuring Consistent Medication Appearance 2Medication Non-Adherence Issue Highlighted in Annals of Internal Medicine Study Could Be Eliminated by a New Direct-to-Consumer Delivery Channel Ensuring Consistent Medication Appearance 3Lilly Reports Second-Quarter 2014 Results 2Lilly Reports Second-Quarter 2014 Results 3Lilly Reports Second-Quarter 2014 Results 4Lilly Reports Second-Quarter 2014 Results 5Lilly Reports Second-Quarter 2014 Results 6Lilly Reports Second-Quarter 2014 Results 7Lilly Reports Second-Quarter 2014 Results 8Lilly Reports Second-Quarter 2014 Results 9Lilly Reports Second-Quarter 2014 Results 10Lilly Reports Second-Quarter 2014 Results 11Lilly Reports Second-Quarter 2014 Results 12Lilly Reports Second-Quarter 2014 Results 13Lilly Reports Second-Quarter 2014 Results 14Lilly Reports Second-Quarter 2014 Results 15Lilly Reports Second-Quarter 2014 Results 16Lilly Reports Second-Quarter 2014 Results 17Lilly Reports Second-Quarter 2014 Results 18Lilly Reports Second-Quarter 2014 Results 19Lilly Reports Second-Quarter 2014 Results 20Lilly Reports Second-Quarter 2014 Results 21Lilly Reports Second-Quarter 2014 Results 22Lilly Reports Second-Quarter 2014 Results 23Lilly Reports Second-Quarter 2014 Results 24
... CHICAGO , Aug. 5 Advanced Life ... ADLS ), a biopharmaceutical company engaged in ... therapeutic areas of infection, oncology and respiratory diseases, today announced ... pick for August, 2010 by "The KonLin Letter," a 27 ...
... Landau Uniforms, the nation,s leading quality health care apparel manufacturer, has donated more ... efforts. , , , ... committed to providing ongoing, long-term support for Haiti as it struggles ... Sales and Marketing for Landau Uniforms. "We understand the recovery process is ...
Cached Medicine Technology:Advanced Life Sciences Featured as Special Stock Pick by KonLin Investment Letter 2Advanced Life Sciences Featured as Special Stock Pick by KonLin Investment Letter 3Advanced Life Sciences Featured as Special Stock Pick by KonLin Investment Letter 4Landau Uniforms Donates $600,000 in Scrubs to Haiti Relief 2
The Vitatron Slimtine S lead series are endocardial leads with an excellent history of reliability and optimal handling en pacing performance....
Unipolar Atrial "J" Lead...
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
Medicine Products: